Arihant Capital Markets to Halt Trading April 1 for FY26 Results Disclosure

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Arihant Capital Markets to Halt Trading April 1 for FY26 Results Disclosure
Overview

Arihant Capital Markets Limited will close its trading window starting April 1, 2026, ahead of announcing its audited financial results for the fiscal year ending March 31, 2026. This regulatory move prohibits designated employees and their relatives from trading until 48 hours after the results are declared, upholding market integrity.

Arihant Capital Markets Halts Trading April 1 for FY26 Results

Trading closes April 1, 2026, and will reopen 48 hours after financial results are announced.

Trading Window Closure Explained

Arihant Capital Markets Limited will enforce a trading window closure for its designated persons and their immediate relatives starting April 1, 2026. This is a routine regulatory step mandated by SEBI's (Prohibition of Insider Trading) Regulations, 2015.

This closure prevents trading based on non-public, price-sensitive information. The window is set to reopen a minimum of 48 hours after the company officially declares its audited financial results for the fiscal year ending March 31, 2026. This ensures all key financial details are public before trading resumes, upholding market fairness.

Importance for Market Integrity

These closures are vital for maintaining market integrity and investor confidence. They prevent individuals with access to non-public financial data from gaining an unfair advantage. SEBI mandates this to promote a level playing field for all investors and ensure transparency in India's capital markets.

Company Background and Past Scrutiny

Arihant Capital Markets, a financial services firm established in 1992, operates as a stock and commodity broker offering a range of financial products. The company has a history of implementing trading window closures before financial result announcements. Its internal controls include codes of conduct for insider trading and pre-clearance for significant trades.

However, the company has faced regulatory scrutiny previously. In April 2023, it settled a case with SEBI for alleged violations of broker norms, paying over Rs 17 lakh concerning client fund segregation and off-market dealings.

Impact of the Closure

  • For Designated Persons: Direct prohibition from trading Arihant Capital securities from April 1, 2026, until the window reopens.
  • For Immediate Relatives: Similar restrictions apply to immediate relatives, preventing trading activity during the closure.
  • For Investors: This closure indicates the company is finalizing its annual financial performance.
  • Market Integrity: Reinforces the commitment to SEBI's fair trading practices.

Compliance and Reputational Risks

  • Non-compliance: Trading by designated persons or relatives during the closed window violates SEBI regulations and could lead to penalties.
  • Reputational Risk: Previous regulatory settlements, such as the one in April 2023 regarding broker norms, highlight the importance of strict adherence to compliance.

Industry Norms

Peers like Motilal Oswal Financial Services and Angel One also follow similar SEBI regulations. They also implement trading window closures to ensure transparency and prevent insider trading around earnings.

Looking Ahead

  • Board Meeting Date: The date of the board meeting to approve audited financial results for FY2025-2026 is a key upcoming event.
  • Financial Results: The actual financial numbers and commentary will offer insights into performance.
  • Trading Window Reopening: Confirmation of the exact date and time the trading window will reopen.
  • Company Announcements: Any further company announcements on financial results or the trading window.
Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.